A cabazitaxel liposome for increased solubility, enhanced antitumor effect and reduced systemic toxicity

The potential side effects of cabazitaxel (CBZ) in the field of cancer treatment have become a great limitation to its further clinical application. Liposomal delivery is a well-established approach to increase the therapeutic index of hydrophobic drugs. In this study, a PEG-modified liposome was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xiaoyi, Luo, Lihua, Li, Wei, Yang, Jie, Zhu, Chunqi, Jiang, Mengshi, qin, Bing, Yuan, Xiaoling, Yin, Hang, Lu, Yichao, Du, Yongzhong, Chen, Dawei, You, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032206/
https://www.ncbi.nlm.nih.gov/pubmed/32104492
http://dx.doi.org/10.1016/j.ajps.2018.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032206/
https://www.ncbi.nlm.nih.gov/pubmed/32104492
http://dx.doi.org/10.1016/j.ajps.2018.10.004

Ejemplares similares